About
Principal health economist providing methodological expertise to NICE
Develops health economic models for cost effectiveness of health technologies
Co-ordinator of Introduction to Health Economics short course
Research
Research groups
Current research
REFLEX study. Reflex testing for metabolic associated fatty liver disease (MAFLD) in patients living with type 2 diabetes compared to usual care – a randomised controlled trial.
MODERNISED Enlighten. Cost-effective multi-cancer early detection by measuring patient plasma amino acid cross sections with the Enlighten test.
TRAIN - A Phase III Randomised Control Clinical Trial Of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy For High-risk Non-muscle Invasive Bladder Cancer
The REMACS study (Understanding The Impact Of Perineal Reconstruction After Extended MArgin Cancer Surgery On Long-term Quality Of Life, Operative And Health Economic Outcomes)
WRAPPED (Women’s Responses to Adjusted Product Placement and it’s Effects on Diet) WRAPPED (Women’s Responses to Adjusted Product Placement and it’s Effects on Diet) – MRCLEC (soton.ac.uk)
EACh-B Engaging Adolescents in Changing Behaviour EACH-B | LifeLab | University of Southampton
Research projects
Active projects
Completed projects
Publications
Teaching
Co-ordinator of SHTAC's short course, Introduction to Health Economics Evaluation Course Training | Southampton Health Technology Assessments Centre (SHTAC) | University of Southampton
Biography
Keith works as a Principal Research Fellow for SHTAC. Keith has been a member of the SHTAC executive group since 2015 and leads the Health Economics Modelling Group meetings.
Keith was awarded his PhD in 2005 following a four year project in the Department of Management at the University of Southampton developing a health care simulation for coronary heart disease, for the Department of Health.
Since joining SHTAC in September 2005, Keith has provided health economics expertise for a number of Technology Assessment Reports for NICE including the clinical and cost-effectiveness of treatments for hepatitis C, psoriasis, cancer (multiple myeloma, lung, lymphoma, breast cancer), and asthma.
He has also contributed to NIHR HTA Programme funded projects including behavioural interventions for the prevention of sexually transmitted infections in young people, long-term weight management schemes for adults, and educational interventions for preventing vascular catheter bloodstream infections in critical care.
His current research includes health economic modelling for the WRAPPED, EACH-B, REFLEX and Multi-Cancer Early Detection (MCED) studies and economic evaluations within trials for REMACS and TRAIN trials.